2013 FDA Drug Approval Calendar
TheStreet.com
- Adcetris
- Amag Pharmaceuticals
- Amarin
- Antares
- Auxilium
- Aveo Pharmaceuticals
- Cubist Pharmaceuticals
- dabrafenib
- Delcath
- Depomed
- Dolutegravir
- drug approvals
- efinaconazole
- Entereg
- Feraheme
- Gilead
- GSK
- Melblez
- Merck
- Otrexup
- Seattle Genetics
- Sefelsa
- sofosbuvir
- suvorexant
- tivozanib
- Trametenib
- Valeant Pharmaceuticals
- Vascepa
- Xiaflex
- Zogenix
- Zohydro
Narrower-than-Expected Loss at Seattle Genetics
Yahoo/Zacks
Anything Can Happen This Year For Celldex
Seeking Alpha
Five Super Ideas in the Healthcare Sector
Motley Fool
4 Healthcare Stock Stories for TGIF Wellness
Wall Street Cheat Street
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Biotech Corner: Monoclonal Antibody Companies
Seeking Alpha